ENTA – Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals, Inc.ENTA
$14.14Name : Enanta Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $410,176,800.00
EPSttm : -3.21
Enanta Pharmaceuticals, Inc.
$14.14
0.81%$0.115Float Short %
8.19
Margin Of Safety %
Put/Call OI Ratio
0.27
EPS Next Q Diff
EPS Last/This Y
1.02
EPS This/Next Y
0.21
Price
14.27
Target Price
17.8
Analyst Recom
1.6
Performance Q
23.81
Relative Volume
0.68
Beta
0.98
Ticker: ENTA
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-13 | ENTA | 13.11 | 0.13 | 0.00 | 2754 |
| 2026-01-14 | ENTA | 13.86 | 0.12 | 999.99 | 2802 |
| 2026-01-15 | ENTA | 13.35 | 0.12 | 0.15 | 2805 |
| 2026-01-16 | ENTA | 12.6 | 0.11 | 0.00 | 2798 |
| 2026-01-20 | ENTA | 12.51 | 0.08 | 0.16 | 1084 |
| 2026-01-21 | ENTA | 12.58 | 0.08 | 12.00 | 1149 |
| 2026-01-22 | ENTA | 12.83 | 0.12 | 4.00 | 1188 |
| 2026-01-23 | ENTA | 13.03 | 0.13 | 0.00 | 1206 |
| 2026-01-26 | ENTA | 12.91 | 0.12 | 100.00 | 1279 |
| 2026-01-27 | ENTA | 13.03 | 0.21 | 0.00 | 1378 |
| 2026-01-28 | ENTA | 12.66 | 0.21 | 35.00 | 1381 |
| 2026-01-29 | ENTA | 12.95 | 0.27 | 0.00 | 1452 |
| 2026-01-30 | ENTA | 12.81 | 0.27 | 999.99 | 1452 |
| 2026-02-02 | ENTA | 13.21 | 0.28 | 0.00 | 1462 |
| 2026-02-03 | ENTA | 13.55 | 0.28 | 2.50 | 1461 |
| 2026-02-04 | ENTA | 13.45 | 0.28 | 0.00 | 1464 |
| 2026-02-05 | ENTA | 12.98 | 0.28 | 0.00 | 1464 |
| 2026-02-06 | ENTA | 13.53 | 0.27 | 0.00 | 1526 |
| 2026-02-09 | ENTA | 13.81 | 0.27 | 1.00 | 1527 |
| 2026-02-10 | ENTA | 14.12 | 0.27 | 0.06 | 1527 |
| 2026-02-11 | ENTA | 14.23 | 0.27 | 0.00 | 1528 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-13 | ENTA | 13.12 | 23.1 | - | -3.07 |
| 2026-01-14 | ENTA | 13.85 | 23.1 | - | -3.07 |
| 2026-01-15 | ENTA | 13.38 | 23.1 | - | -3.07 |
| 2026-01-16 | ENTA | 12.61 | 23.1 | - | -3.07 |
| 2026-01-20 | ENTA | 12.50 | 23.1 | - | -3.07 |
| 2026-01-21 | ENTA | 12.56 | 23.1 | - | -3.07 |
| 2026-01-22 | ENTA | 12.81 | 23.1 | - | -3.07 |
| 2026-01-23 | ENTA | 13.02 | 23.1 | - | -3.07 |
| 2026-01-26 | ENTA | 12.94 | 23.1 | - | -3.07 |
| 2026-01-27 | ENTA | 12.98 | 23.1 | - | -3.07 |
| 2026-01-28 | ENTA | 12.67 | 23.1 | - | -3.07 |
| 2026-01-29 | ENTA | 12.91 | 23.1 | - | -3.07 |
| 2026-01-30 | ENTA | 12.90 | 16.6 | - | -3.09 |
| 2026-02-02 | ENTA | 13.22 | 16.6 | - | -3.09 |
| 2026-02-03 | ENTA | 13.54 | 16.6 | - | -3.09 |
| 2026-02-04 | ENTA | 13.46 | 16.6 | - | -3.09 |
| 2026-02-05 | ENTA | 12.98 | 16.6 | - | -3.09 |
| 2026-02-06 | ENTA | 13.49 | 16.6 | - | -3.09 |
| 2026-02-09 | ENTA | 13.86 | 16.6 | - | -3.09 |
| 2026-02-10 | ENTA | 14.10 | 16.6 | - | -3.09 |
| 2026-02-11 | ENTA | 14.27 | 16.6 | - | -2.82 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-13 | ENTA | -0.88 | 15.46 | 7.60 |
| 2026-01-14 | ENTA | -0.88 | 15.46 | 7.60 |
| 2026-01-15 | ENTA | -0.88 | 15.46 | 7.60 |
| 2026-01-16 | ENTA | -0.88 | 15.46 | 7.60 |
| 2026-01-20 | ENTA | -0.88 | 15.33 | 7.60 |
| 2026-01-21 | ENTA | -0.88 | 15.33 | 7.60 |
| 2026-01-22 | ENTA | -0.88 | 15.33 | 7.60 |
| 2026-01-23 | ENTA | -0.88 | 15.33 | 7.60 |
| 2026-01-26 | ENTA | -0.88 | 16.50 | 7.60 |
| 2026-01-27 | ENTA | -0.88 | 16.50 | 7.60 |
| 2026-01-28 | ENTA | -0.88 | 16.50 | 8.22 |
| 2026-01-29 | ENTA | -0.88 | 16.50 | 8.22 |
| 2026-01-30 | ENTA | -0.88 | 16.50 | 8.22 |
| 2026-02-02 | ENTA | -0.88 | 16.46 | 8.17 |
| 2026-02-03 | ENTA | -0.89 | 16.46 | 8.17 |
| 2026-02-04 | ENTA | -0.89 | 16.46 | 8.17 |
| 2026-02-05 | ENTA | -0.89 | 16.46 | 8.17 |
| 2026-02-06 | ENTA | -0.89 | 16.46 | 8.17 |
| 2026-02-10 | ENTA | -0.89 | 19.57 | 8.17 |
| 2026-02-11 | ENTA | -0.89 | 19.57 | 8.19 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.69
Avg. EPS Est. Next Quarter
-0.64
Insider Transactions
-0.89
Institutional Transactions
19.57
Beta
0.98
Average Sales Estimate Current Quarter
16
Average Sales Estimate Next Quarter
15
Fair Value
Quality Score
20
Growth Score
26
Sentiment Score
77
Actual DrawDown %
86
Max Drawdown 5-Year %
-95.6
Target Price
17.8
P/E
Forward P/E
PEG
P/S
6.17
P/B
4.71
P/Free Cash Flow
EPS
-3.2
Average EPS Est. Cur. Y
-2.82
EPS Next Y. (Est.)
-2.61
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-106.8
Relative Volume
0.68
Return on Equity vs Sector %
-154.4
Return on Equity vs Industry %
-138
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.24
EBIT Estimation
Enanta Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 120
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis. It has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
stock quote shares ENTA – Enanta Pharmaceuticals Inc Stock Price stock today
news today ENTA – Enanta Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ENTA – Enanta Pharmaceuticals Inc yahoo finance google finance
stock history ENTA – Enanta Pharmaceuticals Inc invest stock market
stock prices ENTA premarket after hours
ticker ENTA fair value insiders trading